- Including results for Busulfan.Do you want results only for Basulfan?
- See moreSee all on Wikipedia
Busulfan - Wikipedia
Busulfan (Myleran, GlaxoSmithKline, Busulfex IV, Otsuka America Pharmaceutical, Inc.) is a chemotherapy drug in use since 1959. It is a cell cycle non-specific alkylating antineoplastic agent, in the class of alkyl sulfonates. Its chemical designation is 1,4-butanediol dimethanesulfonate. See more
Busulfan was approved by the US Food and Drug Administration (FDA) for treatment of chronic myeloid leukemia (CML) in 1999. Busulfan was the mainstay of the See more
Myleran is supplied in white film coated tablets with 2 mg of busulfan per tablet. After 2002, a great interest has appeared for intravenous … See more
Toxicity may include interstitial pulmonary fibrosis ("busulfan lung"), hyperpigmentation, seizures, hepatic (veno-occlusive disease) … See more
Busulfan is metabolized via glutathione conjugation in the liver to inactive metabolites. Itraconazole can decrease busulfan clearance by up to 25%, resulting in AUC levels >1500 micromolxmin and increased risk of hepatic VOD. Concomitant use of See more
Busulfan is used in pediatrics and adults in combination with cyclophosphamide or fludarabine/clofarabine as a conditioning agent prior to bone marrow transplantation, especially in chronic myelogenous leukemia (CML) and other leukemias, lymphomas See more
As an adjunct therapy with cyclophosphamide for conditioning prior to bone marrow transplantation in adults and children >12 kg, intravenous (IV) busulfan (Bulsulfex) is dosed at 0.8 mg/kg every six hours for 16 doses (four days). IV busulfan is usually … See more
Busulfan is an alkylsulfonate. It is an alkylating agent that forms DNA-DNA interstrand crosslinks between the DNA bases See more
Wikipedia text under CC-BY-SA license Busulfan oral/injection Uses, Side Effects & Warnings - Drugs.com
Busulfan: MedlinePlus Drug Information
Busulfan Tablet: Indications, Side Effects, Warnings - Drugs.com
Busulfan - NCI - National Cancer Institute
Busulfan (intravenous route) - Mayo Clinic
Busulfan - StatPearls - NCBI Bookshelf
Mar 10, 2024 · Busulfan is an alkylating antineoplastic agent administered to patients since the 1950s. FDA-Approved Indications. The FDA-approved indication for busulfan is for use with cyclophosphamide as part of the regimen …
Busulfan Monograph for Professionals - Drugs.com
Busulfan: Dosage, Mechanism/Onset of Action, Half …
Feb 17, 2020 · Busulfan is an alkylating agent which reacts with the N-7 position of guanosine and interferes with DNA replication and transcription of RNA. Busulfan has a more marked effect on myeloid cells than on lymphoid cells …
Busulfan: Uses, Interactions, Mechanism of Action
715 rows · Busulfan is a bifunctional alkylating agent, having a selective immunosuppressive effect on bone marrow. It is not a structural analog of the nitrogen mustards. It has been used in the palliative treatment of chronic …
- Including results for Busulfan.Do you want results only for Basulfan?